Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

Newer Clinical Applications Set to Drive European Molecular Imaging Markets, States Frost & Sullivan

publication date: Jan 15, 2013
 | 
author/source: Frost & Sullivan

Rapid technological advances will highlight the need for skilled technicians and physicians


Frost and SullivanIn addition to oncology and cardiology, the next big field of clinical application for molecular imaging will be neurology. This expanding user base is expected to boost revenues for the European molecular imaging market.

New analysis from Frost & Sullivan, European Molecular Imaging Markets, finds that the markets earned revenues of $276.0 million in 2011 and estimates this to reach $388.4 million in 2018. The research covers positron emission tomography (PET), single photon emission computed tomography (SPECT) and planar segments.

“The discovery of novel radiotracers is expanding the use of molecular imaging diagnostics to newer clinical applications,” notes Frost & Sullivan Research Analyst Kaavya Karunanithi. “In addition to the traditional fields of oncology and cardiology, neurology as well as infectious and inflammatory disease segments are increasingly leveraging molecular imaging techniques with radiotracers, thus widening the application base.”

Market penetration is also being fuelled by the heightened prevalence and awareness of cancer. Procedural volumes of various cancer screening modalities, including PET and PET/CT, are rising. Furthermore, the ability to facilitate personalised treatment is motivating the use of molecular imaging technologies.

Technological innovations too continue to drive growth in the molecular imaging markets. For instance, hybrids such as the recently introduced PET/MRI offer higher specificities than currently available PET/CT.

“In the long run, optical modalities and tri-modality systems, with the ability to cater to a wider clinical application portfolio, will dominate,” adds Kaavya. “Such technically advanced offerings boost market prospects, even while addressing the demand for personalised medicine.”

With rapid advancements in technology, there is an urgent need for skilled technicians and physicians to effectively acquire and interpret images. This is an important challenge, which needs to be addressed.

“Market participants must stay abreast of the high degree of technological change,” advises Kaavya. “They will need to provide innovative, accurate and reliable solutions that facilitate personalised medical care.”

If you are interested in more information on this study, please send an email with your contact details to Anna Zanchi, Corporate Communications, at anna.zanchi@frost.com

European Molecular Imaging Markets is part of the Advanced Medical Technologies Growth Partnership Service programme, which also includes research in the following markets: European Market for Computed Tomography, Global Trends in Medical Imaging–Cardiology Applications, and European Mobile Imaging Services Market. All research included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants


 



 

News Channels

 

 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 

 

 

 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events